These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28192483)

  • 21. Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.
    Shimanovich AA; Buskirk AD; Heine SJ; Blackwelder WC; Wahid R; Kotloff KL; Pasetti MF
    Clin Vaccine Immunol; 2017 Feb; 24(2):. PubMed ID: 27927680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay.
    Ison CA; Anwar N; Cole MJ; Galassini R; Heyderman RS; Klein NJ; West J; Pollard AJ; Morley S; Levin and the Meningococcal Re
    Microb Pathog; 1999 Oct; 27(4):207-14. PubMed ID: 10502461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.
    Romero-Steiner S; Spear W; Brown N; Holder P; Hennessy T; Gomez De Leon P; Carlone GM
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):89-93. PubMed ID: 14715550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b.
    Kim HW; Kim KH; Kim J; Nahm MH
    BMC Infect Dis; 2016 Sep; 16(1):473. PubMed ID: 27595992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal
    Aruta MG; De Simone D; Dale H; Chirwa E; Kadwala I; Mbewe M; Banda H; Gordon M; Pizza M; Berlanda Scorza F; Nyirenda T; Canals R; Rossi O; On Behalf Of The Vacc-iNTS Consortium Collaborators
    Methods Protoc; 2022 Dec; 5(6):. PubMed ID: 36548142
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.
    Partridge E; Lujan E; Giuntini S; Vu DM; Granoff DM
    Vaccine; 2017 Jul; 35(33):4236-4244. PubMed ID: 28651840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
    Frasch CE; Borrow R; Donnelly J
    Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella.
    Siggins MK; MacLennan CA
    Vaccine; 2021 Dec; 39(51):7503-7509. PubMed ID: 34794820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
    Findlow J; Holland A; Martin D; Oster P; Balmer P; Borrow R
    Clin Vaccine Immunol; 2007 May; 14(5):556-61. PubMed ID: 17344344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H
    Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay.
    Findlow J; Holland A; Andrews N; Weynants V; Sotolongo F; Balmer P; Poolman J; Borrow R
    Clin Vaccine Immunol; 2007 Nov; 14(11):1451-7. PubMed ID: 17881507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of Shigella strains to bactericidal activity of human serum. I. Participation of two independently active mechanisms in bactericidal action against Shigella sonnei phase II.
    Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
    Acta Microbiol Pol; 1990; 39(3-4):111-6. PubMed ID: 1715644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of Shigella strains to the bactericidal activity of human serum. II. Shigella flexneri 3 a is killed by complement activated via the classical pathway, with participation of lysozyme.
    Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
    Acta Microbiol Pol; 1990; 39(3-4):117-20. PubMed ID: 1715645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.
    Brunelli B; Del Tordello E; Palumbo E; Biolchi A; Bambini S; Comanducci M; Muzzi A; Pizza M; Rappuoli R; Donnelly JJ; Giuliani MM; Serruto D
    Vaccine; 2011 Jan; 29(5):1072-81. PubMed ID: 21130753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of Shigella strains to the bactericidal activity of human serum. III. The diversity of activity variants of bactericidal serum factors against Shigella flexneri serotypes.
    Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
    Acta Microbiol Pol; 1990; 39(3-4):121-7. PubMed ID: 1715646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the bactericidal antibody against Neisseria meningitidis serogroup C strains after immunization with a divalent polysaccharide (A plus C) vaccine].
    Xu L; Luo LZ; Zhu BQ; He L; Gao Y; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):619-21. PubMed ID: 19957632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
    Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
    Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.